Readability of Online Info About Pancreatic Cancer Varies

This article originally appeared here.
Share this content:
Readability of Online Info About Pancreatic Cancer Varies
Readability of Online Info About Pancreatic Cancer Varies

THURSDAY, May 5, 2016 (HealthDay News) -- The readability and accuracy of online information regarding pancreatic cancer varies, according to a study published online May 4 in JAMA Surgery.

Alessandra Storino, M.D., from the Beth Israel Deaconess Medical Center and Harvard Medical School in Boston, and colleagues compared the readability and accuracy of patient-oriented online resources for pancreatic cancer. Fifty websites discussing five pancreatic cancer treatment modalities were searched; the website's affiliation was identified. The median readability level of each website was computed using nine standardized tests.

The researchers found that the websites varied in terms of readability and accuracy based on the focus of treatment modality and the website's affiliation. Websites discussing surgery were easier to read than those discussing radiotherapy and clinical trials (median readability level, 13.7 versus 15.2 and 15.2, respectively; P = 0.003 and 0.002, respectively). Websites of nonprofit organizations were easier to read than media and academic websites (median readability level, 12.9 versus 16.0 and 14.8, respectively; both P < 0.001); privately owned websites were easier to read than media websites (median readability level, 14.0 versus 16.0; P = 0.001). The lowest accuracy scores were seen for alternative therapy websites (median accuracy score, 2; P < 0.001). Websites with higher accuracy were more difficult to read than those with lower accuracy.

"In the absence of quality control on the internet, physicians should provide guidance to patients in the selection of online resources with readable and accurate information," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

FDA Approves New Parkinson's Add-On Drug Xadago

FDA Approves New Parkinson's Add-On Drug Xadago

To help prevent 'off' episodes among users of levodopa/carbidopa

Infant Mortality Down in United States From 2005 to 2014

Infant Mortality Down in United States From 2005 ...

Largest decreases seen for infants of Asian or Pacific Islander and non-Hispanic black women

Intensive Strategy Addresses Hypoxemia After Cardiac Surgery

Intensive Strategy Addresses Hypoxemia After Cardiac Surgery

Intensive alveolar recruitment strategy linked to less severe pulmonary complications after cardiac sx

is free, fast, and customized just for you!

Already a member?

Sign In Now »